Recent Press Releases
- Renovia raises $17M in Series C-1 financing
- Renovia names new president and CEO; Completes enrollment for randomized controlled trial.
- Renovia presents at Piper Sandler Healthcare Conference
- Renovia Announces FDA 510(k) Clearance of Next-Generation leva® Pelvic Digital Therapeutic
- Renovia Study Results Published in Neurology and Urodynamics Show Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence
- Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards